Home
ConcertAI

ConcertAI Market Share Analysis for August 2026

ConcertAI orchestrates clinical expertise, real-world data, and applied AI to deliver practical intelligence for the demands of oncology and other complex diseases.

Health > Biotechnology and Pharmaceuticals

Domainconcertai.com

Year Founded2018

Employees1001 - 5000

Annual Revenue$100M - $200M

ConcertAI

ConcertAI (including company regionals)

concertai.com

See more website traffic and engagement information

ConcertAI Revenue up to August 2026 is 100M - 200M

revenue generated by ConcertAI top domains

ConcertAI top domains revenue over 3 years

Revenue for ConcertAI top domains

concertai.com100M - 200M

See more with Sales Intelligence

Total visits to ConcertAI's top domains

Understand ConcertAI market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

concertai.com32.4K

See more with Sales Intelligence

Avg. visit duration in ConcertAI's top domains

Analyze ConcertAI engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

concertai.com00:02:57

See more with Sales Intelligence

Avg. pageviews on ConcertAI's top domains

See how ConcertAI keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

concertai.com3.44

See more with Sales Intelligence

ConcertAI top competitors by domain

Top similar sites in August 2026, ranked by their affinity

tempus.comCompany NameTempusEmployees1001 - 5000HQUnited States, Illinois, ChicagoAnnual revenue> $1BTotal visits154.1KHealth > Health Conditions and Concerns

Top technologies used by ConcertAI

These are the website technologies, by industry, used by ConcertAI top domains

Advertising (9)

DoubleClick

Marketing (7)

Google Marketing Platform

Conversion & Analytics (5)

Google Analytics

Widget (5)

Yoast SEO

More Technologies

14

See all

News & Signals from ConcertAI

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsConcertAI, LLC launched capabilities for CancerLinQ platform on Jul 9th '26.ConcertAI announced new capabilities for its CancerLinQ platform that extend well beyond automated quality reporting.

NewsAmerican Society Of Clinical Oncology, Inc. sold assets to ConcertAI, LLC on Dec 1st '23.The platform has since become central to ConcertAI, an oncology-focused AI and real-world data company, which acquired it from ASCO in December 2023.

NewsConcertAI, LLC launches clinically intelligent advancements to CancerLinQ Suite at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.To convert this massive lake of unstructured medical text into a continuous system of clinical action, real-world healthcare intelligence pioneer ConcertAI has unveiled major, clinically intelligent advancements to its CancerLinQ Suite.